Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Panel Discussion
View:
Post by Quentin30 on Apr 15, 2024 12:35pm

Panel Discussion

Looks like the Panel Discussion went down well... after Matt speaking PPS is only down 6 and a half percent... I wonder if that's a new record.

Keep loading up the truck folks...
Comment by Azzak34 on Apr 15, 2024 1:03pm
But, but as a shareholder that sentiment hurts your bottom line Quentin no?
Comment by lonc17 on Apr 15, 2024 1:24pm
There is a noticeable correlation between Matt's appearances in public and a decline in ONC's shareprice. He has lilttle credibility left after over promising and under delivering for half a decade. Lately his enthusiasm feels forced and he can be difficult to listen to.  ONC would be far better served with a new CEO who can deliver something of substance. 
Comment by Azzak34 on Apr 15, 2024 1:30pm
After you embarrassed yourself last week your back with more guesswork?  "Our" stock has been following the bond market, as is most pharma and biotech. Very easy to check, spend the time and go back to look. Matt's appearances have nothing to do with it. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities